Q3 2024 saw 8% revenue growth and a 14% EBITDA increase, but US and Brazil market slowdowns led to a downgrade in 2024 guidance. A €50m+ cost reduction program and a shift to recurring revenue share aim to position for future growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.